Welcome to LookChem.com Sign In|Join Free

CAS

  • or

163526-35-0

Post Buying Request

163526-35-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

163526-35-0 Usage

Classification

Piperazine derivative

Usage

Pharmaceutical intermediate, building block for drug synthesis

Potential Applications

Treatment of central nervous system disorders, development of new medications for other medical conditions

Importance

Valuable tool for researchers and drug developers in the pharmaceutical industry

Unique Features

Chemical structure and properties

Check Digit Verification of cas no

The CAS Registry Mumber 163526-35-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,3,5,2 and 6 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 163526-35:
(8*1)+(7*6)+(6*3)+(5*5)+(4*2)+(3*6)+(2*3)+(1*5)=130
130 % 10 = 0
So 163526-35-0 is a valid CAS Registry Number.

163526-35-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-Cyclopentyl-3-methylpiperazine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:163526-35-0 SDS

163526-35-0Downstream Products

163526-35-0Relevant articles and documents

Synthesis of 1,4-disubstituted-2-methylpiperazines and study of their analgesic properties

Barlocco,Brunello,Bernardi,Cignarella

, p. 119 - 124 (2007/10/02)

A series of N,N-disubstituted-2-methylpiperazines (3a-e) has been synthesized and compounds tested both in vitro and in vivo for their analgesic properties. Binding studies showed that the new compounds are devoid of relevant affinity towards μ receptors. However, compound 3a displayed significant analgesic properties both in the hot plate test and in the mouse phenyl-p-benzoquinone induced abdominal constriction test (MAC), whereas the other derivatives were found active only in MAC test. Moreover, it should be noted that compound 3a elicited a Straub-tail reaction also at the lowest administered dose (10 mg/kg, ip) and this effect was antagonized by naloxone.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 163526-35-0